STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
79 hedge funds and large institutions have $143M invested in Stemline Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
28% less call options, than puts
Call options by funds: $1.22M | Put options by funds: $1.7M
Holders
79
Holding in Top 10
–
Calls
$1.22M
Puts
$1.7M
Top Buyers
| 1 | +$7.3M | |
| 2 | +$4.62M | |
| 3 | +$1.78M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$1.13M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.1M |
Top Sellers
| 1 | -$5.96M | |
| 2 | -$3.43M | |
| 3 | -$3M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.6M |
| 5 |
CCI
Columbus Circle Investors
|
-$618K |